First trial will measure safely and tolerability, but they usually report any improvements in symptoms even if that isn't the purpose of the study. Any any improvements will cause huge excitement. I'm not aware of any drug available to help this disorder. Once it develops it's all downhill from there.
we'll be smelling the roses soon., page-8
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.99 |
Change
0.540(2.64%) |
Mkt cap ! $2.682B | |||
| Open | High | Low | Value | Volume |
| $20.56 | $21.55 | $20.54 | $12.48M | 591.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 435 | $20.97 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.99 | 1001 | 2 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |